Dana Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1996.
1996 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited, a active private limited company, was established on 07 August 1996 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239MH1996PTC101669. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹4.05 Cr and a paid-up capital of ₹3.81 Cr.

It upholds a compliant status. Employing 8 professional, Its leadership includes Suresh Sagarmal Parmar (Director), Abhai Sachidanand Attavar (Director), Gautam Hathiramani Ramesh (Director). Past directors included Sabita Ramesh Hathiramani, Suresh Sagarmal Parmar, Abhai Sachidanand Attavar. It holds ₹5.05 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 209,Bhaveshwar Complex,Vidyavihar (W), Mumbai-86., Mumbai, Maharashtra.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1996PTC101669

  • Registration Number

    101669

  • Incorporation Date

    07 August 1996

  • Authorized Capital

    ₹4.05 Cr

  • Paid-Up Capital

    ₹3.81 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.05 Cr
  • Paid Up Capital ₹ 3.81 Cr
  • Company Age 29 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.05 Cr
  • Revenue Growth **** -7.41%
  • Profit Growth **** 266.77%
  • Ebitda **** -218.77%
  • Net Worth 6.54%
  • Total Assets **** 31.19%
Company report

Dana Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Dana Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Dana Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Suresh Sagarmal Parmar Director 02 Aug 2022 Current
Abhai Sachidanand Attavar Director 02 Aug 2022 Current
Gautam Hathiramani Ramesh Director 07 Aug 1996 Current
Jacky Ramesh Hathiramani Director 07 Aug 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Nov 2014 Past
Pramod Abcsdd Additional Director 22 Sep 2022 Past
Pramod Abcsdd Additional Director 22 Sep 2022 Past
Pramod Abcsdd Director 03 Aug 2022 Past
Pramod Abcsdd Director 03 Aug 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dana Pharmaceuticals.

Dana Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.41% decrease. The company also saw a substantial improvement in profitability, with a 266.77% increase in profit. The company's net worth moved up by a moderate rise of 6.54%.

Dana Pharmaceuticals revenue growth over time
Dana Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -7.41%
*******
*******
*******
*******
Revenue from Operations
*******
 -8.86%
*******
*******
*******
*******
Total Assets
*******
 31.19%
*******
*******
*******
*******
Profit or Loss
*******
 266.77%
*******
*******
*******
*******
Net Worth
*******
 6.54%
*******
*******
*******
*******
EBITDA
*******
 -218.77%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dana Pharmaceuticals?

Unlock access to Dana Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 5.05 Cr
Latest Charge Details
Date Lender Amount Status
26 Mar 2010 Indian Overseas Bank ₹1.00 Cr Open
28 Mar 2008 Indian Overseas Bank ₹5.00 M Open
28 Mar 2008 Indian Overseas Bank ₹1.80 Cr Open
15 Oct 1997 Indian Overseas Bank ₹3.50 M Open
29 Sep 1997 Indian Overseas Bank ₹5.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Dana Pharmaceuticals?

Dana Pharmaceuticals has a workforce of 8 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dana Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dana Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dana Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Dana Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Dana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Suresh Sagarmal Parmar was appointed as a Director was appointed as a Director on 02 Aug 2022 & has been associated with this company since 3 years 6 months . was completed.

  • Director Appointment

    Abhai Sachidanand Attavar was appointed as a Director was appointed as a Director on 02 Aug 2022 & has been associated with this company since 3 years 6 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Indian Overseas Bank of Rs. 1.00 Cr registered on 26 Mar 2010 with Charge ID 10213566 was modified on 21 Dec 2017. was documented.

  • Charges

    The activity A charge with Indian Overseas Bank amounted to Rs. 1.00 Cr with Charge ID 10213566 was registered on 26 Mar 2010. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dana Pharmaceuticals Private Limited?

The CIN of Dana Pharmaceuticals Private Limited is U24239MH1996PTC101669.

Where is Dana Pharmaceuticals Private Limited headquartered?

Dana Pharmaceuticals Private Limited is headquartered at 209,Bhaveshwar Complex,Vidyavihar (W), Mumbai-86., Mumbai, Maharashtra.

When was Dana Pharmaceuticals Private Limited incorporated?

Dana Pharmaceuticals Private Limited was incorporated on 07 August 1996.

Who are the current directors of Dana Pharmaceuticals Private Limited?

The current directors of Dana Pharmaceuticals Private Limited are

What is the primary industry of Dana Pharmaceuticals Private Limited?

The primary industry of Dana Pharmaceuticals Private Limited is Trade.

Is Dana Pharmaceuticals Private Limited a listed company?

Dana Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dana Pharmaceuticals Private Limited?

The authorized capital of Dana Pharmaceuticals Private Limited is ₹4.05 Cr, and the paid-up capital is ₹3.81 Cr.

What is the compliance status of Dana Pharmaceuticals Private Limited?

The compliance status of Dana Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available